| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2147.18 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2773.32 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 3110.15 | 99 |
| GSM780719 | Untreated after 4 days (C1_2) | 2380.36 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 3289.94 | 99 |
| GSM780721 | Untreated after 4 days (C3_2) | 3160.76 | 99 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 3085.54 | 99 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2524.38 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2621.34 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 2921.56 | 99 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2711.66 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2621.34 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2537.86 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2988.92 | 99 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2716.11 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2958.95 | 99 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 3094.33 | 99 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2572.58 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2869.79 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2814.19 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2841.6 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2826.11 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2668.32 | 98 |